(WIS) - Hundreds of bike riders will be peddling across South Carolina for a good cause.
Friday marks the 10th annual 'A Ride to Remember' event and is put on by the Alzheimer's Association. The goal is to raise money and find a cure to end Alzheimer's disease.
350 cyclists will ride 252 miles from Simpsonville to Mt. Pleasant over the course of 3 days.
This event will raise money to provide Alzheimer's support services, education and research to find a cure for this disease.
Alzheimer's is the most common form of dementia, a general term for memory loss and other cognitive abilities serious enough to interfere with daily life.
The disease gets worse over time, which means people who are diagnosed could possibly live with the disease for 8 to 10 years. The annual 'A Ride to Remember' event is one of the largest events the Alzheimer's Association holds to raise money for this disease.
It started 10 years ago with 16 cyclists who raised a couple thousand dollars. Now, 350 cyclists will be riding and their goal is to reach $750,000 dollars.
"These 350 cyclists and volunteers all have a connection to this disease," Taylor Wilson, director of communications and advocacy for the Alzheimer's Association South Carolina chapter said. "Alzheimer's affects 89,000 South Carolinians currently and 309,000 people trying to care give for them. South Carolina currently has the highest death rate to Alzheimer's in America.
"These cyclists are leading the charge and making a change to find our first survivor to end Alzheimer's."
Ron Hagell, a first time rider in the event, tells WIS he's riding for his father who he lost to dementia in 2015.
"There's a concern about what's happening. It's happening to so many people and I'm hoping that there will be improvements and help for all the people that are getting older and approaching the age where lots of people have this disease," Hagell said.
The funds raised at this event will stay in South Carolina.
The money will be used to provide support for families facing a dementia diagnosis as well as research to find an end to Alzheimer's.